BCL9L and neoplasm: We analysed the mRNA expression of BCL9L in the matched microdissected NMIBC and MIBC tumour tissues of eight patients with progressive disease (patient no. 1 to 8, Table 1) as well as in three ureters from non-bladder cancer patients.